CFGS
CRL icon

Concourse Financial Group Securities’s Charles River Laboratories CRL Stock Holding History

Concourse Financial Group Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-735
Closed -$124K – 423
2024
Q4 		$124K Sell
735
-238
-24% -$45.8K 0.01% 882
2024
Q3 		$192K Sell
973
-33
-3% -$6.86K 0.01% 726
2024
Q2 		$208K Buy
1,006
+119
+13% +$27K 0.01% 679
2024
Q1 		$240K Buy
887
+29
+3% +$6.92K 0.02% 620
2023
Q4 		$203K Sell
858
-98
-10% -$19.3K 0.01% 654
2023
Q3 		$187K Sell
956
-52
-5% -$10.7K 0.01% 638
2023
Q2 		$212K Buy
1,008
+119
+13% +$23.7K 0.02% 625
2023
Q1 		$179K Buy
889
+13
+1% +$2.95K 0.01% 677
2022
Q4 		$191K Sell
876
-82
-9% -$17.9K 0.02% 620
2022
Q3 		$189K Sell
958
-2,115
-69% -$457K 0.02% 551
2022
Q2 		$658K Sell
3,073
-157
-5% -$38.4K 0.06% 341
2022
Q1 		$917K Sell
3,230
-137
-4% -$42.2K 0.07% 285
2021
Q4 		$1.27M Buy
3,367
+441
+15% +$171K 0.07% 274
2021
Q3 		$1.21M Buy
2,926
+192
+7% +$79.7K 0.07% 268
2021
Q2 		$1.01M Buy
2,734
+277
+11% +$92.5K 0.06% 295
2021
Q1 		$712K Sell
2,457
-14
-0.6% -$3.89K 0.05% 345
2020
Q4 		$617K Buy
2,471
+353
+17% +$84.1K 0.05% 345
2020
Q3 		$480K Buy
2,118
+398
+23% +$82.6K 0.04% 347
2020
Q2 		$300K Buy
1,720
+2
+0.1% +$319 0.03% 417
2020
Q1 		$217K Buy
1,718
+220
+15% +$33K 0.02% 439
2019
Q4 		$229K Buy
1,498
+1,439
+2,439% +$199K 0.02% 474
2019
Q3 		$8K Sell
59
-117
-66% -$15.7K ﹤0.01% 1200
2019
Q2 		$25K Buy
176
+124
+238% +$16.8K ﹤0.01% 1158
2019
Q1 		$7K Sell
52
-6
-10% -$788 ﹤0.01% 1625
2018
Q4 		$6K Sell
58
-7
-11% -$876 ﹤0.01% 1572
2018
Q3 		$9K Buy
+65
New +$8.02K ﹤0.01% 1134

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Concourse Financial Group Securities's CRL Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 735 shares — an estimated $124K sold.

Concourse Financial Group Securities first reported a position in CRL in Q3 2018 and held it in 26 quarters. The position peaked at $1.27M in Q4 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 735 Charles River Laboratories shares in Q1 2025, an estimated $124K.
  • Concourse Financial Group Securities first reported a position in Charles River Laboratories in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Charles River Laboratories position peaked at $1.27M in Q4 2021.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.